Trial Information
Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting
Inclusion Criteria:
- All patients undergoing an allograft for hematological malignancies
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Authority:
Italy: Ministry of Health
Study ID:
LAM Allo SCT
NCT ID:
NCT00876148
Start Date:
Completion Date:
Related Keywords:
- Hepatitis B Virus
- Allograft
- Hematological Malignancies
- Incidence of hepatitis B after allografting
- Risk of hepatitis B reactivation
- Lamivudine prophylaxis
- Neoplasms
- Hepatitis
- Hepatitis A
- Hepatitis B
- Virus Diseases
- Hematologic Neoplasms